Purchase Order HT941026PE064
Award Date 4/15/26
Potential Completion Date 4/14/31
Potential Value $4.7M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Millcreek, UT 84107, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $1.54M firm fixed-price purchase order to Biofire Defense LLC on April 15, 2025, for the procurement of a molecular assay analyzer with an ultimate completion date of April 14, 2026. The equipment will be delivered to Camp Pendleton North, California. Biofire Defense, a Salt Lake City-based manufacturer of molecular diagnostic technologies, specializes in rapid pathogen identification systems and has been an established federal contractor since 2001. This...
- The Defense Health Agency awarded a $3.14 million firm fixed-price purchase order to Biofire Diagnostics LLC for a molecular assay-analyzer system to support the Naval Medical Center Portsmouth, Virginia. The contract, which was awarded on April 16, 2020, with an ultimate completion date of April 15, 2025, provides laboratory analyzer equipment, associated reagents, maintenance, and consumables capable of performing syndromic infectious disease testing. The analyzer must test for respiratory,...
- <p>The Defense Health Agency awarded a purchase order to Biofire Defense LLC for an automated molecular multiplex PCR system to detect DNA/RNA pathogens on April 15, 2026, with a ceiling value of $2,259,153.85. Place of performance is Portsmouth, Virginia. The order is firm fixed price with an ultimate completion date of April 14, 2031. No set-aside was used.</p>
- The Defense Health Agency issued a delivery order to Biofire Defense LLC on October 1, 2025, for equipment lease of two multiplex molecular analyzer systems and testing panel reagents at Madigan Army Medical Center, with a ceiling value of $968,331.59 and an ultimate completion date of September 30, 2026. This delivery order is issued under a $4.85 million Indefinite Delivery Contract with the Defense Health Agency (awarded October 1, 2025, through September 2030) that establishes the...
- The Defense Health Agency (DHA) awarded a $5.42 million firm fixed-price purchase order to Biofire Defense LLC for molecular infectious disease polymerase chain reaction (PCR) testing services, effective October 1, 2025, through September 30, 2026, with an ultimate completion date of September 30, 2030. This non-set-aside contract represents DHA's continued investment in advanced diagnostic capabilities for infectious disease detection and biodefense applications. Biofire Defense, a Salt Lake...
- <p>The Office of Logisitics and Acquisition Operations issued a $222,202.51 delivery order to Biofire Defense LLC on January 8, 2025, to add funding to Option Year 1 for BioFire reagent panels.</p> <p>Place of performance is Millcreek, UT. The order carries a firm fixed price and an ultimate completion date of September 30, 2026. No set-aside was used.</p>
- The Defense Health Agency awarded a $828,024.90 firm fixed price delivery order to Biofire Defense LLC under an unspecified contract vehicle. The order is for respiratory panel testing services to support DHA programs. Work will be performed in Salt Lake City, Utah through December 31, 2021. The prime contractor will provide respiratory disease diagnostic panels to assist the Defense Health Agency in monitoring the health of military personnel. No subcontractors or set-aside designations were...
- The Defense Health Agency (DHA) awarded a $3.5 million firm fixed-price purchase order to Biofire Defense LLC on September 30, 2024, for molecular diagnostic kits with a completion date of September 29, 2029. This contract, which includes no set-aside designation, will be performed in Bethesda, Maryland. Biofire Defense is a specialized manufacturer of biological agent identification and molecular diagnostic solutions based in Salt Lake City, Utah, known for its FilmArray and RAZOR Mk II systems...
- The Defense Health Agency (DOD) awarded a $746,778 firm fixed price purchase order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is for the delivery of 184 kits containing 30 tests each of Biofire Defense's RESPIRATORY PANEL 2.1 in vitro diagnostic test panels. The place of performance is Biofire Defense's facility in Salt Lake City and the period of performance runs from June 16, 2022 through September 14, 2022. The contract was awarded under the National Interest Action...
- The Defense Health Agency awarded a purchase order to Biofire Diagnostics LLC for $1,881,825.06 on October 1, 2020, for BioFire blood culture identification, respiratory, and meningitis diagnostic panels supporting Tripler Army Medical Center in Hawaii. Place of performance is Emigration Canyon, Utah. The order is firm fixed price with an ultimate completion date of September 30, 2025. The procurement originated from a pre-solicitation notice posted May 26, 2020, seeking FDA-approved molecular...